Posters
« Back
Comparison of Fluorescence Lifetime and Fluorescence Intensity Readouts using a Homogeneous Protease-assay
EP20185
Comparison of Fluorescence Lifetime and Fluorescence Intensity Readouts using a Homogeneous Protease-assay
Submitted on 19 Dec 2013

Joachim Janda, Michael Busch, Christoph Wenger and Ralf Thiericke
CyBio
Poster Views: 608
View poster »
Poster Abstract
In this work two measurement parameters are compared, the fluorescence intensity (FI) and fluorescence lifetime (FLT), which could be acquired efficiently in a multi parameter readout from one and the same measurement.

The biochemical reaction being investigated consists of a fluorescent labelled enzyme-substrate (case in as a biopolymer carrying BODIPY FL), which is cleaved by the protease a-chymotrypsin.

In the beginning of the assay the fluorescence signal is internally quenched as a result of energy transfer interactions among the BODIPY labels. The continuous fragmentation of the biopolymer backbone in consequence of enzymatic degradation leads to a rise of the fluorescence signal while the quenching effects decrease. In the assay this is expressed in an increase of both, intensity and lifetime.
Report abuse »
Creative Commons

Related Posters


Gene Mining Spinal and Dental Phenotypes of the Collaborative Cross
Samuel Bennett, Eason Guo, Curtise Ng, Grant Morahan, Jennifer Tickner, Jiake Xu

Gene Mining the Spinal and Dental Phenotypes of the Collaborative Cross
Samuel Bennett, Eason Guo, Curtise Ng, Grant Morahan, Jennifer Tickner, Jiake Xu

Caracterización de propóleo rojo de la zona insular de San Andrés, Colombia, mediante resonancia magnética nuclear protónica
Guillermo Salamanca Grosso; Monica Patricia Osorio Tangarife; David Fernando García Mendez; Julien Wist

The MODEL-AD consortium preclinical testing pipeline: pharmacokinetics and pharmacodynamics of prophylactic treatment with levetiracetam on the 5XFAD mouse model of Alzheimer’s Disease
SJ Sukoff Rizzo1, SK Quinney2, KD Onos1, KJ Keezer1, DR Jones2, AR Masters2, IF Metzger2, JA Meyer2, J Peters2, SC Persohn2, BR McCarthy2, AA Riley2, M Sasner1, G Howell1, H Williams1, AJ Oblak2, BL Lamb2, and PR Territo2

MODEL-AD: Late-Onset Alzheimer’s Disease Models
Bruce Lamb on behalf of the MODEL-AD Consortium